ATRS

Antares Pharma News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Antares Pharma Inc ATRS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.005 0.09% 5.58 16:01:50
Open Price Low Price High Price Close Price Prev Close
5.58 5.57 5.58 5.58 5.575
more quote information »

Recent News

Date Time Source Heading
5/17/20227:30IHNWFeaturedAmerican Green, Inc. ™ (OTC:ERBB) Officially Acquires Vendweb - Supplier of its AGX Facial Recognition and Over- 21 Age Smart Vending Machine
5/13/202216:46EDGARAmended Statement of Ownership: Solicitation (sc 14d9/a)
5/12/202208:00PRNUSHart-Scott-Rodino Waiting Period Expires for Halozyme's..
5/12/202207:13EDGARAmended Statement of Ownership: Solicitation (sc 14d9/a)
5/12/202207:02EDGARAmended Tender Offer Statement by Third Party (sc To-t/a)
5/10/202217:28EDGARQuarterly Report (10-q)
5/10/202216:42EDGARAmended Statement of Ownership: Solicitation (sc 14d9/a)
5/06/202212:10EDGARStatement of Ownership (sc 13g)
5/02/202217:08EDGARAmended Tender Offer Statement by Third Party (sc To-t/a)
5/02/202216:50BWANTARES PHARMA INVESTOR ALERT - Kuznicki Law PLLC..
5/02/202206:03EDGARStatement of Beneficial Ownership (sc 13d)
4/29/202217:56EDGARAmended Annual Report (10-k/a)
4/26/202207:17EDGARStatement of Ownership: Solicitation (sc 14d9)
4/26/202207:02EDGARTender Offer Statement by Third Party (sc To-t)
4/14/202206:10EDGARWritten Communication Relating to an Issuer or Third Party..
4/13/202217:28EDGARWritten Communication Relating to an Issuer or Third Party..
4/13/202217:27EDGARWritten Communication Relating to an Issuer or Third Party..
4/13/202209:21EDGARCurrent Report Filing (8-k)
4/13/202206:00PRNUSHalozyme to Acquire Antares Pharma to Create a Specialty..
3/29/202208:04SEEKAntares wins full FDA approval for testosterone replacement..
3/29/202207:00GLOBEAntares Pharma Announces FDA Approval Of TLANDO™, an Oral..
3/07/202208:59EDGARCurrent Report Filing (8-k)
3/07/202206:16TRMNAnalysts Are Bullish on Top Healthcare Stocks: Aclaris..
3/04/202218:39EDGARStatement of Changes in Beneficial Ownership (4)
3/04/202218:37EDGARStatement of Changes in Beneficial Ownership (4)
3/04/202218:35EDGARStatement of Changes in Beneficial Ownership (4)
3/03/202208:10EDGARCurrent Report Filing (8-k)
3/03/202207:01SEEKAntares Pharma Non-GAAP EPS of $0.02 beats by $0.01, revenue..
3/03/202207:00GLOBEAntares Pharma Reports Fourth Quarter and Full-Year 2021..
3/02/202211:49SEEKAntares Pharma Q4 2021 Earnings Preview
2/28/202208:30GLOBEAntares Pharma to Present at the Cowen 42nd Annual..
2/17/202208:30GLOBEAntares Pharma To Report Fourth Quarter And Full-Year 2021..
2/14/202209:08EDGARStatement of Ownership (sc 13g)
2/03/202209:26SEEKAntares resubmitted NDA for testosterone replacement therapy..
2/03/202208:00GLOBEAntares Pharma Announces FDA Acceptance of NDA Resubmission..
2/01/202217:16EDGARAmended Statement of Ownership (sc 13g/a)
1/18/202212:20SEEKAntares Pharma's ATRS-1902 gets US FDA fast track status for..
1/18/202207:30GLOBEAntares Pharma Receives FDA Fast Track Designation for..
1/12/202209:06EDGARAmended Current Report Filing (8-k/a)
1/12/202208:30GLOBEAntares Pharma Appoints Claude E. Richardson as Senior Vice..
1/11/202209:04EDGARCurrent Report Filing (8-k)
1/11/202209:04SEEKAntares Pharma reports positive results from Phase I..
1/11/202207:30GLOBEAntares Pharma Announces Positive Results From Phase I Study..
12/17/202107:53GLOBEMedMira strengthen its Board with New Appointment
12/16/202116:08EDGARCurrent Report Filing (8-k)
12/15/202117:58GLOBEAntares Pharma Announces Divestiture of Otrexup®
11/22/202108:00GLOBEAntares Pharma to Participate in the Piper Sandler 33rd..
11/10/202108:30GLOBEAntares Pharma to Present at the Jefferies London Healthcare..
11/04/202116:42EDGARQuarterly Report (10-q)
11/04/202107:09EDGARCurrent Report Filing (8-k)
11/04/202107:03SEEKAntares Pharma EPS in-line, beats on revenue


Your Recent History
NASDAQ
ATRS
Antares Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.